In a major push for advanced neurodegenerative disease research in the Caribbean, the government of the Dominican Republic has announced its formal backing for an ambitious Alzheimer’s research project led by two domestic institutions: the Technological Institute of Santo Domingo (INTEC) and AI technology firm AI Robotix. Merging expertise across four cutting-edge fields—artificial intelligence, neuroscience, molecular biology, and data science—the initiative aims to unlock groundbreaking new strategies for the early detection, prevention, and therapeutic intervention of Alzheimer’s, a progressive neurodegenerative condition that affects millions of people globally.
The collaborative project was officially presented to top Dominican government leaders last week during a closed-door meeting held at the National Palace in Santo Domingo. Attendees included President Luis Abinader, Vice President Raquel Peña, and José Ignacio Paliza, Minister of the Presidency. Leading the presentation were Arturo El Villar, rector of INTEC, and Juan Carlos Guilbe, chief executive officer of AI Robotix, who outlined the project’s core objectives and long-term impact potential for both the Dominican Republic and global Alzheimer’s research.
At the core of the project is the application of sophisticated artificial intelligence models, which are designed to process and analyze massive datasets of existing scientific and biomedical research findings. Unlike traditional research methods that require researchers to manually sort through thousands of studies, the AI system can identify subtle, previously unrecognized patterns across disparate datasets and generate evidence-based new hypotheses. These generated hypotheses will then serve as guiding frameworks for future clinical and basic science research into Alzheimer’s treatments, potentially accelerating the pace of discovery dramatically.
The initiative has assembled a diverse team of both domestic and international experts to advance its work, bringing together interdisciplinary perspectives that are rarely combined in traditional Alzheimer’s research. Among the leading global specialists joining the team is Ricardo Allegri, a prominent Argentine neurologist and psychiatrist with decades of acclaimed work in neuroscience and Alzheimer’s research. He will collaborate alongside local lead researcher Manuel Colomé, a professor at INTEC, as well as a cohort of specialized experts in artificial intelligence, molecular biology, and data science from institutions across the region and beyond.
Per statements from INTEC, the project carries far-reaching implications beyond the search for new Alzheimer’s tools and treatments. Institutional leaders noted that the successful execution of the initiative could establish the Dominican Republic as a leading regional hub for high-impact scientific research, technological innovation, and advanced translational health research. Most notably, the project is designed to serve as a global proof of concept, demonstrating how cross-sector collaboration, interdisciplinary expertise, and artificial intelligence can be leveraged to tackle some of the most pressing unmet global health challenges of the 21st century.